These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24807624)

  • 1. Exploring N-acylhydrazone derivatives against clinical resistant bacterial strains.
    Lannes AC; Leal B; Novais JS; Lione V; Monteiro GC; Lourenço AL; Sathler PC; Jordão AK; Rodrigues CR; Cabral LM; Cunha AC; Campos V; Ferreira VF; de Souza MC; Santos DO; Castro HC
    Curr Microbiol; 2014 Sep; 69(3):357-64. PubMed ID: 24807624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, In Vitro and In Silico Studies of Indolequinone Derivatives against Clinically Relevant Bacterial Pathogens.
    Leite TOC; Novais JS; de Carvalho BLC; Ferreira VF; Miceli LA; Fraga L; Abrahim-Vieira B; Rodrigues CR; Sá Figueiredo AM; Castro HC; Cunha AC
    Curr Top Med Chem; 2020; 20(3):192-208. PubMed ID: 31868148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative antibacterial activity of a novel semisynthetic antibiotic: etimicin sulphate and other aminoglycosides.
    Chaudhary M; Kesava Naidu G; Kumar S; Payasi A
    World J Microbiol Biotechnol; 2012 Dec; 28(12):3365-71. PubMed ID: 22983905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-evaluation of in vitro activity of primycin against prevalent multiresistant bacteria.
    Feiszt P; Mestyán G; Kerényi M; Dobay O; Szabó J; Dombrádi Z; Urbán E; Emődy L
    Int J Med Microbiol; 2014 Nov; 304(8):1077-85. PubMed ID: 25179867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient Synthesis and Antibacterial Profile of Bis(2-hydroxynaphthalene- 1,4-dione).
    Novais JS; Rosandiski AC; de Carvalho CM; de Saules Silva LS; Dos S Velasco de Souza LC; Santana MV; Martins NRC; Castro HC; Ferreira VF; Gonzaga DTG; de Resende GO; de C da Silva F
    Curr Top Med Chem; 2020; 20(2):121-131. PubMed ID: 31820692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics.
    Domhan C; Uhl P; Meinhardt A; Zimmermann S; Kleist C; Lindner T; Leotta K; Mier W; Wink M
    Int J Antimicrob Agents; 2018 Jul; 52(1):52-62. PubMed ID: 29649587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of S-(3,4-dichlorobenzyl)isothiourea hydrochloride and novel structurally related compounds against multidrug-resistant bacteria, including Pseudomonas aeruginosa and Burkholderia cepacia complex.
    Nicholson A; Perry JD; James AL; Stanforth SP; Carnell S; Wilkinson K; Anjam Khan CM; De Soyza A; Gould FK
    Int J Antimicrob Agents; 2012 Jan; 39(1):27-32. PubMed ID: 21993484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1beta-methylcarbapenems with potent activities against multiresistant gram-positive bacteria.
    Ueda Y; Sunagawa M
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2471-80. PubMed ID: 12878507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic antimicrobial activity of combinations of sanguinarine and EDTA with vancomycin against multidrug resistant bacteria.
    Hamoud R; Reichling J; Wink M
    Drug Metab Lett; 2014; 8(2):119-28. PubMed ID: 25692301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gepotidacin (GSK2140944)
    Flamm RK; Farrell DJ; Rhomberg PR; Scangarella-Oman NE; Sader HS
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyathea gigantea (Cyatheaceae) as an antimicrobial agent against multidrug resistant organisms.
    Nath K; Talukdar AD; Bhattacharya MK; Bhowmik D; Chetri S; Choudhury D; Mitra A; Choudhury NA
    BMC Complement Altern Med; 2019 Oct; 19(1):279. PubMed ID: 31640666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria.
    Putnam SD; Castanheira M; Moet GJ; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):393-401. PubMed ID: 20022192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro spectrum of pexiganan activity; bactericidal action and resistance selection tested against pathogens with elevated MIC values to topical agents.
    Flamm RK; Rhomberg PR; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2016 Sep; 86(1):66-9. PubMed ID: 27352729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial.
    Zhang Z; Chen M; Yu Y; Pan S; Liu Y
    Antimicrob Resist Infect Control; 2018; 7():152. PubMed ID: 30564308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles.
    Kamal A; Hussaini SM; Faazil S; Poornachandra Y; Narender Reddy G; Kumar CG; Rajput VS; Rani C; Sharma R; Khan IA; Jagadeesh Babu N
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6842-6. PubMed ID: 24206766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Antimicrobial Activities of Organic Acids and Their Derivatives on Several Species of Gram-Negative and Gram-Positive Bacteria.
    Kovanda L; Zhang W; Wei X; Luo J; Wu X; Atwill ER; Vaessen S; Li X; Liu Y
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31635062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Bioactivity of Hydrazide-Hydrazones with the 1-Adamantyl-Carbonyl Moiety.
    Pham VH; Phan TPD; Phan DC; Vu BD
    Molecules; 2019 Nov; 24(21):. PubMed ID: 31694218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.
    Peric M; Browne FA; Jacobs MR; Appelbaum PC
    Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro assessment of Ag2O nanoparticles toxicity against Gram-positive and Gram-negative bacteria.
    Negi H; Rathinavelu Saravanan P; Agarwal T; Ghulam Haider Zaidi M; Goel R
    J Gen Appl Microbiol; 2013; 59(1):83-8. PubMed ID: 23518522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of para-guanidinoethylcalix[4]arene against susceptible and antibiotic-resistant Gram-negative and Gram-positive bacteria.
    Grare M; Mourer M; Fontanay S; Regnouf-de-Vains JB; Finance C; Duval RE
    J Antimicrob Chemother; 2007 Sep; 60(3):575-81. PubMed ID: 17626025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.